CRISPR and Fanzor in sickle cell disease: current progress and future prospects
{{output}}
Advancements in genome editing have established a new frontier for the treatment of various genetic diseases, including sickle cell disease (SCD). SCD, the most prevalent monogenic blood disorder, causes severe pain, organ damage, and reduced life expectancy. ... ...